JENNIFER WARREN: Open Payments
NPI 1174872626 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 52 payments from 12 companies in 2025. Trend: 2023 $889 · 2024 $874 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $251 |
| ABBVIE INC. | 14 | $138 |
| Amgen Inc. | 4 | $60 |
| Novo Nordisk Inc | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 4 | $49 |
| Boston Scientific Corporation | 1 | $47 |
| Electromed, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Dexcom, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, UBRELVY, VOQUEZNA, CDS - MCT/CEM Monitoring, OTEZLA, SMARTVEST, JARDIANCE, QULIPTA.
Industry payments across MS — which companies pay providers there.
